BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Will the Pfizer-BioNTech Vaccine Protect Against New COVID-19 Strain?

  In a December 8, 2020 meeting with U.K. scientists and public health experts, it was announced that there was a growing new strain of the SARS-CoV-2 virus that causes COVID-19.

  December 22, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Biopharma Update on the Novel Coronavirus: December 29

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.

  December 22, 2020

   · 

  2 min read

   · 

  BioSpace Editorial Staff
• 

  Policy

  Biopharma Update on the Novel Coronavirus: December 22

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.

  December 22, 2020

   · 

  4 min read

   · 

  BioSpace Editorial Staff
• 

  BioCapital

  NIH Team Isolates Promising Llama Nanobody Against COVID-19

  It has been thought that llamas may hold the key to developing an effective therapeutic against COVID-19, as well as the flu. This morning, scientists from the National Institutes of Health made additional headway in llama research, isolating promising antibodies from the South American animal.

  December 22, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Rhythm Pharmaceuticals’ Anti-Obesity Drug Setmelanotide Shows Promising Findings in Phase III Trial

  Rhythm Pharmaceuticals announced on Tuesday that its hunger and severe obesity drug, setmelanotide, significantly reduced weight and hunger scores in people with Bardet-Biedl syndrome and Alström syndrome.

  December 22, 2020

   · 

  3 min read

   · 

  Brandon May
• 

  Drug Development

  Study Suggests Link Between Sleep Supplement and COVID-19

  At the moment, eight clinical trials are currently being carried out to determine if the link between melatonin and the novel coronavirus is legitimate.

  December 22, 2020

   · 

  2 min read

   · 

  Krystle Vermes
• 

  FDA

  Four Recent FDA Drug Approvals: Myovant, Integrum, AstraZeneca and Ridgeback

  The U.S. Food and Drug Administration has approved several drugs and medical devices in the last week. Here’s a look.

  December 22, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Skyhawk and Vertex Team Up on RNA Splicing-Based Therapies

  Skyhawk Therapeutics and Vertex Pharmaceuticals inked a strategic research collaboration and licensing deal focused on developing novel small molecules that modulate RNA splicing.

  December 22, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Amgen-AstraZeneca Experimental Asthma Drug Surprisingly Flops in Phase III

  An investigational asthma treatment, tezepelumab, under development by Amgen and AstraZeneca failed to reduce asthma patients’ dependence on corticosteroids.

  December 22, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Research Roundup: UK Strain of COVID-19 and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  December 22, 2020

   · 

  5 min read

   · 

  Mark Terry